Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
roflumilast (daliresp) (2 trials)
fluticasone (cutivate) (1 trial)
salmeterol (serevent) (1 trial)
budesonide (rhinocort) (1 trial)
formoterol (foradil) (1 trial)
Asthma (Phase 3)
Chronic Disease (Phase 4)
Lung Diseases (Phase 4)
Pulmonary Disease, Chronic Obstructive (Phase 4)
Trials (4 total)
Trial APIs (5 total)